Metformin use is associated with reduced odds of new-onset International Classification of Diseases (ICD) coding of ...

Please provide your email address to receive an email when new articles are posted on . Continuous growth of macular neovascularization size, as well as development of outer retina atrophy, was ...

Age-related macular degeneration blinds more older adults in Western countries than any other retinal disease. Neovascular AMD, while less common than its dry counterpart, causes nearly all cases of ...

Please provide your email address to receive an email when new articles are posted on . “There is no doubt that visual acuity improves with anti-VEGF treatment, at least for the first 3 years,” ...

Regular aspirin use might up the risk of age-related macular degeneration. Jan. 22, 2013— -- Regular aspirin use is linked to an increased risk of vision loss with age, a new study found. The ...

Patients with diabetes using glucagon-like peptide 1 receptor agonists (GLP-1 RAs) may face more than twice the risk for developing neovascular age-related macular degeneration compared with those not ...

"It is not necessary to measure the extent, height, or length of the DLS [double layer sign]. It is sufficient to know, however, that when DLS is seen that it’s a key risk factor and that regular ...

Retinal and choroidal vascular diseases are principal causes of blindness for adults in developed countries around the world. Neovascular age-related macular degeneration (nAMD) and diabetic macular ...

Migaldendranib (MGB) is a new class of targeted nanomedicine for the treatment of diabetic macular edema (DME) and neovascular age-related macular degeneration (nAMD) with a novel mechanism of action ...